Redefining
recovery in
critical care

FMS (Functional Magnetic Stimulation) enables deep neuromuscular activation, helping preserve muscle function and prevent atrophy in ICU patients—without effort or discomfort.

Designed for early-stage intervention, where preserving function is critical.

Muscle function can decline quickly. Intervention shouldn't wait.

In the ICU, patients are often immobilized and highly prone to rapid muscle loss. Although early intervention is critical, many solutions cannot be applied at this stage: they depend on patient participation, require direct skin contact, or are difficult to use in closely monitored patients.

Electrostimulation

Limited penetration into deep tissues. Requires direct contact

Lower comfort at effective intensities

Application limited by patient condition

Requires consumables (e.g. electrodes), increasing treatment costs

Deep stimulation without contact

High tolerance, even at elevated intensities

Applicable from early stages, without patient participation

No consumables required, reducing ongoing operating costs

There is a clear gap between what patients need from the start and what conventional therapies actually allow

FMS: neuromuscular activation from the very first moment

FMS (Functional Magnetic Stimulation) uses high-intensity magnetic fields to induce electrical currents in tissues, directly activating nerves and muscles without the need for contact. This enables treatment when other therapies cannot be used.

What it enables in clinical practice:

Induce effective muscle contractions

Apply therapy over clothing, bandages, or immobilization devices

Initiate treatment from early stages

Activate deep muscle groups without patient participation

Key biological effects:
PAIN RELIEF

Analgesic effect in acute and chronic pain.

NON-INVASIVE NEUROMODULATION

Modulation of neural activity to improve control and functional response.

DEEP NEUROMUSCULAR STIMULATION

Effective activation of neuromuscular activity to enhance activation and functional rehabilitation.

BIOLOGICAL AND TISSUE RESPONSE

Supports recovery processes, including muscle and bone tissue.

What happens in the ICU defines recovery

Muscle deterioration during critical care stays has a direct impact on patient outcomes.
Loss of muscle mass is associated with:

Maintaining muscle activity from early stages helps preserve function and improves the overall recovery trajectory.

Clinically validated muscle preservation

Significant reduction in muscle loss compared to conventional physiotherapy

Preservation of muscle thickness (measured by ultrasound)

Improved strength in treated muscle groups

Access clinical studies and scientific evidence

Designed for real ICU workflows.

Built for efficiency and better outcomes.

Magneto Care is designed to integrate seamlessly into ICU workflows, enabling consistent delivery of neuromuscular therapy without increasing workload.

Designed for real ICU workflows.

Built for efficiency and better outcomes.

Magneto Care is designed to integrate seamlessly into ICU workflows, enabling consistent delivery of neuromuscular therapy without increasing workload.

Explore how FMS can support early intervention in ICU

ISKRA
Inquiry Type
Brand
Address
Address
I am:
I accept the Privacy Policy.

Frequently asked questions

No. Magneto Care induces neuromuscular contractions without voluntary effort, allowing treatment when the patient cannot actively exercise.

Yes. FMS can be applied over clothing, bandages and casts, without direct skin contact.

Yes. Because treatment does not rely on voluntary muscle activation, Magneto Care can support neuromuscular stimulation even when active exercise is limited, according to the clinician’s judgment.

Yes. Magneto Care includes preset programs, with frequency, intensity and duration adjustable according to the patient’s condition and therapeutic goals.

No. Magneto Care operates without consumables or disposable accessories. Once the applicator and protocol are set, treatment does not require continuous operator involvement.